In the realm of orthopedic medicine, the challenge of managing infected bone defects (IBDs) has persisted as a significant ...

LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has grant ...

Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, December 16, 2024Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a ...

In the realm of orthopedic medicine, the challenge of managing infected bone defects (IBDs) has persisted as a significant hurdle. The advent of ...

Basilea enters agreement with Innoviva Specialty Therapeutics for commercialization of antibiotic Zevtera in US: Allschwil, Switzerland Tuesday, December 17, 2024, 15:00 Hrs [IST] ...

LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has ...

"Normal flora" include Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and anaerobes such as Bacteroides species, anaerobic gram-positive cocci, and Fusobacterium species.

Staphylococcus epidermidis exhibits different ... adhesive matrix molecules IsdA and SasF increase survival of S. aureus from antimicrobial fatty acids (AFAs) through different mechanisms.

Irshad Hajam, George Liu, and Chih-Ming Tsai in the Liu lab, Israni Biomedical Research Facility. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to ...

This study provides insights into antibacterial components that could be combined with naturally derived materials through a ...